CONMED CORPORATION Finite-Lived Intangible Asset, Expected Amortization, Year One
CONMED CORPORATION (CNMD) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $36.37 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-07-29
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $36.37M.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $35.31M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $35.38M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $35.31M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $36.37M 10-Q · filed 2026-07-29 |
| 2025-12-31 | $35.31M 10-K · filed 2026-02-17 |
| 2025-09-30 | $35.38M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $35.31M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $35.27M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $35.49M 10-K · filed 2025-02-18 |
| 2024-09-30 | $35.45M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $35.38M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $35.30M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $34.76M 10-K · filed 2024-02-28 |
| 2023-09-30 | $34.73M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $34.81M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $34.77M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $35.35M 10-K · filed 2023-02-21 |
| 2022-09-30 | $35.26M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $34.72M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $31.73M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $32.40M 10-K · filed 2022-02-22 |
| 2021-09-30 | $32.55M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $32.47M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $32.43M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $33.53M 10-K · filed 2021-02-22 |
| 2020-09-30 | $33.52M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $33.45M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $33.45M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $34.06M 10-K · filed 2020-02-24 |
| 2019-09-30 | $33.72M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $33.30M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $33.89M 10-Q · filed 2019-04-26 |
| 2018-12-31 | $23.98M 10-K · filed 2019-02-25 |
| 2018-09-30 | $23.62M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $24.55M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $23.44M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $23.12M 10-K · filed 2018-02-26 |
| 2017-09-30 | $22.78M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $21.93M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $21.82M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $21.54M 10-K · filed 2017-02-27 |
| 2016-09-30 | $21.41M 10-Q · filed 2016-10-28 |
| 2016-06-30 | $21.43M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $21.42M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $12.88M 10-K · filed 2016-02-23 |
| 2015-09-30 | $12.88M 10-Q · filed 2015-10-23 |
| 2015-06-30 | $13.02M 10-Q · filed 2015-07-27 |
| 2015-03-31 | $12.66M 10-Q · filed 2015-04-24 |
| 2014-12-31 | $12.62M 10-K · filed 2015-02-23 |
| 2014-09-30 | $12.54M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $12.65M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $12.67M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $13.03M 10-K · filed 2014-02-24 |
| 2013-09-30 | $13.01M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $7.24M 10-Q · filed 2013-07-29 |
| 2013-03-31 | $7.12M 10-Q · filed 2013-04-29 |
| 2012-12-31 | $7.84M 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |